RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp Presentation at ASX Spotlight Investor Conference, page-3

  1. 5,357 Posts.
    lightbulb Created with Sketch. 1182
    Looks like we'll get an update tomorrow on the Australian Pediatric Study too!!




    Pivotal milestones leading up to first FDA clearance

    2Q2017

    Complete recruitment and lock clinical database for SMARTCOUGH-C study
    Additonal Australian pediatric study results
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.